Patents Assigned to Metronom Health, Inc.
-
Patent number: 11553879Abstract: Certain embodiments described herein pertain to optical sensors, systems and methods for continuous glucose monitoring. In some embodiments, methods of preparing a layered optical sensor are disclosed. The optical sensor can be formed by laminating a plurality of sheets together to form a final sensor. In some embodiments, the sensor tip comprises a oxygen conduit, an enzymatic layer, and an sensing layer. In some embodiments, the sensor includes a plurality of waveguides configured to direct light to and from a target material, such as an oxygen sensing polymer. Systems are also disclosed for an adhesive system for attaching an optical sensor-transmitter system. Methods and systems are also disclosed for a sensor inserter system. The inserter can include a lancet tip that includes a convex feature attached to a first surface of the lancet tip.Type: GrantFiled: September 1, 2016Date of Patent: January 17, 2023Assignee: Metronom Health, Inc.Inventor: Troy M. Bremer
-
Patent number: 11439351Abstract: Certain embodiments described herein pertain to optical sensors, systems and methods for continuous glucose monitoring. In some embodiments, methods of preparing a layered optical sensor are disclosed. The optical sensor can be formed by laminating a plurality of sheets together to form a final sensor. In some embodiments, the sensor tip comprises a oxygen conduit, an enzymatic layer, and an sensing layer. In some embodiments, the sensor includes a plurality of waveguides configured to direct light to and from a target material, such as an oxygen sensing polymer. Systems are also disclosed for an adhesive system for attaching an optical sensor-transmitter system. Methods and systems are also disclosed for a sensor inserter system. The inserter can include a lancet tip that includes a convex feature attached to a first surface of the lancet tip.Type: GrantFiled: November 16, 2018Date of Patent: September 13, 2022Assignee: Metronom Health, Inc.Inventor: Troy M. Bremer
-
Patent number: 11389089Abstract: An inserter for a medical device, where the inserter includes a housing having a first end with an opening therein, an actuator connected to a first gear, an actuator biasing element, a cam gear assembly including a cam member and a second gear, a cam bridge follower in contact with the cam member, and a first plunger assembly having a first plunger and a first biasing element.Type: GrantFiled: April 19, 2018Date of Patent: July 19, 2022Assignee: Metronom Health, Inc.Inventors: Troy M. Bremer, Barry Lyons
-
Patent number: 11160474Abstract: Provided herein is a stabilized oxygen transport matrix that includes a reversible oxygen binding protein, such as hemoglobin, immobilized throughout the stabilized oxygen transport matrix. The stabilized oxygen transport matrix is used to transport oxygen and can be used as an oxygen transport region and a reaction region of an analyte sensor, such as an implantable glucose sensor. The reversible binding protein can also function as an oxygen probe within the analyte sensor.Type: GrantFiled: May 27, 2016Date of Patent: November 2, 2021Assignee: Metronom Health, Inc.Inventors: Elliot Botvinick, Troy M. Bremer
-
Patent number: 10695000Abstract: Certain embodiments described herein pertain to optical sensors, systems and methods for continuous glucose monitoring. In some embodiments, methods of preparing a layered optical sensor are disclosed. The optical sensor can be formed by laminating a plurality of sheets together to form a final sensor. In some embodiments, the sensor tip comprises a oxygen conduit, an enzymatic layer, and an sensing layer. In some embodiments, the sensor includes a plurality of waveguides configured to direct light to and from a target material, such as an oxygen sensing polymer. Systems are also disclosed for an adhesive system for attaching an optical sensor-transmitter system. Methods and systems are also disclosed for a sensor inserter system. The inserter can include a lancet tip that includes a convex feature attached to a first surface of the lancet tip.Type: GrantFiled: September 1, 2016Date of Patent: June 30, 2020Assignee: Metronom Health, Inc.Inventor: Troy M. Bremer
-
Patent number: 9357952Abstract: Provided herein is a stabilized oxygen transport matrix that includes a reversible oxygen binding protein, such as hemoglobin, immobilized throughout the stabilized oxygen transport matrix. The stabilized oxygen transport matrix is used to transport oxygen and can be used as an oxygen transport region and a reaction region of an analyte sensor, such as an implantable glucose sensor. The reversible binding protein can also function as an oxygen probe within the analyte sensor.Type: GrantFiled: September 23, 2013Date of Patent: June 7, 2016Assignee: Metronom Health, Inc.Inventors: Elliot Botvinick, Troy M. Bremer
-
Publication number: 20140163345Abstract: Provided herein is a stabilized oxygen transport matrix that includes a reversible oxygen binding protein, such as hemoglobin, immobilized throughout the stabilized oxygen transport matrix. The stabilized oxygen transport matrix is used to transport oxygen and can be used as an oxygen transport region and a reaction region of an analyte sensor, such as an implantable glucose sensor. The reversible binding protein can also function as an oxygen probe within the analyte sensor.Type: ApplicationFiled: September 23, 2013Publication date: June 12, 2014Applicant: Metronom Health, Inc.Inventors: Elliot Botvinick, Troy M. Bremer
-
Patent number: 8543182Abstract: Provided herein is a stabilized oxygen transport matrix that includes a reversible oxygen binding protein, such as hemoglobin, immobilized throughout the stabilized oxygen transport matrix. The stabilized oxygen transport matrix is used to transport oxygen and can be used as an oxygen transport region and a reaction region of an analyte sensor, such as an implantable glucose sensor. The reversible binding protein can also function as an oxygen probe within the analyte sensor.Type: GrantFiled: June 29, 2006Date of Patent: September 24, 2013Assignee: Metronom Health, Inc.Inventors: Elliot Botvinick, Troy M. Bremer
-
Patent number: D887425Type: GrantFiled: August 22, 2018Date of Patent: June 16, 2020Assignee: METRONOM HEALTH, INC.Inventor: Troy M. Bremer